drugset / Trial / NCT02909439

Quality of Recovery After Reversal With Neostigmine or Sugammadex.

NCT02909439

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will compare patient recovery measures after reversal of neuromuscular blockade with neostigmine or sugammadex after surgery. Measures include pulmonary function, muscle strength, time to extubation and quality of recovery in the post anesthesia care unit.

Timeline

Start
2016-11
Primary completion
2017-11-09
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 70 ug/kg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg

Indications

No indication recorded.